{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T17:54:05Z","timestamp":1792086845145,"version":"4.4.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,11,25]],"date-time":"2020-11-25T00:00:00Z","timestamp":1606262400000},"content-version":"am","delay-in-days":360,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","ejso.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Surgical Oncology"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.ejso.2019.05.007","type":"journal-article","created":{"date-parts":[[2019,5,9]],"date-time":"2019-05-09T11:17:35Z","timestamp":1557400655000},"page":"2386-2391","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":59,"title":["Oxaliplatin use in pressurized intraperitoneal aerosol chemotherapy (PIPAC) is safe and effective: A multicenter study"],"prefix":"10.1016","volume":"45","author":[{"given":"Olivia","family":"Sgarbura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"H\u00fcbner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Alyami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clarisse","family":"Eveno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Gagni\u00e8re","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basile","family":"Pache","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Pocard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoual","family":"Bakrin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Qu\u00e9net","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"7","key":"10.1016\/j.ejso.2019.05.007_bib1","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1007\/s00464-012-2148-0","article-title":"Description of a novel approach for intraperitoneal drug delivery and the related device","volume":"26","author":"Solass","year":"2012","journal-title":"Surg Endosc"},{"issue":"11","key":"10.1016\/j.ejso.2019.05.007_bib2","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1016\/j.ejso.2017.09.010","article-title":"Multicentric initial experience with the use of the pressurized intraperitoneal aerosol chemotherapy (PIPAC) in the management of unresectable peritoneal carcinomatosis","volume":"43","author":"Alyami","year":"2017","journal-title":"Eur J Surg Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2019.05.007_bib3","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1245\/s10434-013-3213-1","article-title":"Intraperitoneal chemotherapy of peritoneal carcinomatosis using pressurized aerosol as an alternative to liquid solution: first evidence for efficacy","volume":"21","author":"Solass","year":"2014","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"10.1016\/j.ejso.2019.05.007_bib4","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.ygyno.2018.05.001","article-title":"A\u00a0phase I, single-arm, open-label, dose escalation study of intraperitoneal cisplatin and doxorubicin in patients with recurrent ovarian cancer and peritoneal carcinomatosis","volume":"150","author":"Tempfer","year":"2018","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2019.05.007_bib5","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1093\/annonc\/mdf019","article-title":"Heated intra-operative intraperitoneal oxaliplatin after complete resection of peritoneal carcinomatosis: pharmacokinetics and tissue distribution","volume":"13","author":"Elias","year":"2002","journal-title":"Ann Oncol"},{"key":"10.1016\/j.ejso.2019.05.007_bib6","author":"Dumont","year":"2018"},{"key":"10.1016\/j.ejso.2019.05.007_bib7","series-title":"Study protocol: phase 1 dose escalating study of pressurized intra-peritoneal aerosol chemotherapy (PIPAC) with oxaliplatin in peritoneal metastasis","author":"Kim","year":"2018"},{"key":"10.1016\/j.ejso.2019.05.007_bib8","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/2743985","article-title":"Feasibility, safety, and efficacy of pressurized intraperitoneal aerosol chemotherapy (PIPAC) for peritoneal metastasis: a registry study","volume":"2018","author":"Kurtz","year":"2018","journal-title":"Gastroenterol Res Pract"},{"issue":"6","key":"10.1016\/j.ejso.2019.05.007_bib9","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1002\/bjs.10521","article-title":"Systematic review of pressurized intraperitoneal aerosol chemotherapy for the treatment of advanced peritoneal carcinomatosis","volume":"104","author":"Grass","year":"2017","journal-title":"Br J Surg"},{"issue":"2","key":"10.1016\/j.ejso.2019.05.007_bib10","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s00404-018-4784-7","article-title":"Pressurized intraperitoneal aerosol chemotherapy (PIPAC) for peritoneal carcinomatosis: systematic review of clinical and experimental evidence with special emphasis on ovarian cancer","volume":"298","author":"Tempfer","year":"2018","journal-title":"Arch Gynecol Obstet"},{"issue":"4","key":"10.1016\/j.ejso.2019.05.007_bib11","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1515\/pp-2016-0018","article-title":"Preoperative intraperitoneal oxaliplatin for unresectable peritoneal carcinomatosis of colorectal origin: a pilot study","volume":"1","author":"Sgarbura","year":"2016","journal-title":"Pleura and Peritoneum"},{"issue":"4","key":"10.1016\/j.ejso.2019.05.007_bib12","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.jamcollsurg.2017.12.027","article-title":"A\u00a0multicenter randomized trial to evaluate hematologic toxicities after hyperthermic intraperitoneal chemotherapy with oxaliplatin or mitomycin in patients with appendiceal tumors","volume":"226","author":"Levine","year":"2018","journal-title":"J\u00a0Am Coll Surg"},{"issue":"4","key":"10.1016\/j.ejso.2019.05.007_bib13","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/codi.13130","article-title":"Pressurized intraperitoneal aerosol chemotherapy with oxaliplatin in colorectal peritoneal metastasis","volume":"18","author":"Demtroder","year":"2016","journal-title":"Colorectal Dis"},{"issue":"12","key":"10.1016\/j.ejso.2019.05.007_bib14","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1007\/s11605-018-3916-5","article-title":"How to perform safe and technically optimized pressurized intraperitoneal aerosol chemotherapy (PIPAC): experience after a consecutive series of 1200 procedures","volume":"22","author":"Giger-Pabst","year":"2018","journal-title":"J\u00a0Gastrointest Surg"},{"issue":"6","key":"10.1016\/j.ejso.2019.05.007_bib15","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1016\/j.ejso.2017.03.019","article-title":"Pressurized IntraPeritoneal aerosol chemotherapy - practical aspects","volume":"43","author":"Hubner","year":"2017","journal-title":"Eur J Surg Oncol"},{"issue":"7","key":"10.1016\/j.ejso.2019.05.007_bib16","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/j.ejso.2018.02.014","article-title":"Multicenter comprehensive methodological and technical analysis of 832 pressurized intraperitoneal aerosol chemotherapy (PIPAC) interventions performed in 349 patients for peritoneal carcinomatosis treatment: an international survey study","volume":"44","author":"Nowacki","year":"2018","journal-title":"Eur J Surg Oncol"},{"issue":"3","key":"10.1016\/j.ejso.2019.05.007_bib17","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1016\/j.ejso.2018.10.542","article-title":"HIPEC with oxaliplatin for colorectal peritoneal metastasis: the end of the road?","volume":"45","author":"Ceelen","year":"2019","journal-title":"Eur J Surg Oncol"},{"issue":"3","key":"10.1016\/j.ejso.2019.05.007_bib18","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1007\/s00464-011-1964-y","article-title":"Therapeutic approach of human peritoneal carcinomatosis with dbait in combination with capnoperitoneum: proof of concept","volume":"26","author":"Solass","year":"2012","journal-title":"Surg Endosc"},{"issue":"1","key":"10.1016\/j.ejso.2019.05.007_bib19","first-page":"29","article-title":"Surgical technology and pharmacology of hyperthermic perioperative chemotherapy","volume":"7","author":"Sugarbaker","year":"2016","journal-title":"J\u00a0Gastrointest Oncol"},{"key":"10.1016\/j.ejso.2019.05.007_bib20","article-title":"Severe hypersensitivity reactions to platinum compounds post-pressurized intraperitoneal aerosol chemotherapy (PIPAC): first literature report","author":"Siebert","year":"2018","journal-title":"Cancer Chemother Pharmacol"},{"issue":"3","key":"10.1016\/j.ejso.2019.05.007_bib21","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s10585-018-9895-9","article-title":"Severe peritoneal sclerosis after repeated pressurized intraperitoneal aerosol chemotherapy with oxaliplatin (PIPAC OX): report of two cases and literature survey","volume":"35","author":"Graversen","year":"2018","journal-title":"Clin Exp Metastasis"},{"issue":"2","key":"10.1016\/j.ejso.2019.05.007_bib22","first-page":"93","article-title":"Literature review and practical aspects on the management of oxaliplatin-associated toxicity","volume":"11","author":"Hoff","year":"2012","journal-title":"Clin Colorectal Cancer"},{"issue":"2","key":"10.1016\/j.ejso.2019.05.007_bib23","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.ygyno.2015.02.009","article-title":"Pressurized intraperitoneal aerosol chemotherapy in women with recurrent ovarian cancer: a phase 2 study","volume":"137","author":"Tempfer","year":"2015","journal-title":"Gynecol Oncol"},{"issue":"2","key":"10.1016\/j.ejso.2019.05.007_bib24","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s11605-015-2995-9","article-title":"Pressurized intraperitoneal aerosol chemotherapy (PIPAC) with low-dose cisplatin and doxorubicin in gastric peritoneal metastasis","volume":"20","author":"Nadiradze","year":"2016","journal-title":"J\u00a0Gastrointest Surg"},{"issue":"1","key":"10.1016\/j.ejso.2019.05.007_bib25","first-page":"13","article-title":"Inflammatory response and toxicity after pressurized IntraPeritoneal aerosol chemotherapy","volume":"9","author":"Teixeira","year":"2018","journal-title":"J\u00a0Cancer"},{"issue":"12","key":"10.1016\/j.ejso.2019.05.007_bib26","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1016\/S1470-2045(16)30500-9","article-title":"Prognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: an analysis of individual patient data from prospective randomised trials from the analysis and research in cancers of the digestive system (ARCAD) database","volume":"17","author":"Franko","year":"2016","journal-title":"Lancet Oncol"}],"container-title":["European Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798319304457?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0748798319304457?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:33:00Z","timestamp":1760059980000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0748798319304457"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":26,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["S0748798319304457"],"URL":"https:\/\/doi.org\/10.1016\/j.ejso.2019.05.007","relation":{},"ISSN":["0748-7983"],"issn-type":[{"value":"0748-7983","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oxaliplatin use in pressurized intraperitoneal aerosol chemotherapy (PIPAC) is safe and effective: A multicenter study","name":"articletitle","label":"Article Title"},{"value":"European Journal of Surgical Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejso.2019.05.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd, BASO ~ The Association for Cancer Surgery, and the European Society of Surgical Oncology. All rights reserved.","name":"copyright","label":"Copyright"}]}}